Artia Global Partners

Artia Global Partners as of March 31, 2023

Portfolio Holdings for Artia Global Partners

Artia Global Partners holds 36 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Novo-nordisk A S Adr (NVO) 18.9 $51M 321k 159.14
Merck & Co (MRK) 12.9 $35M 329k 106.39
Biogen Idec (BIIB) 8.2 $22M 80k 278.03
Karuna Therapeutics Ord 6.0 $16M 89k 181.64
Abbvie (ABBV) 5.3 $15M 91k 159.37
Argenx Se Sponsored Adr (ARGX) 5.0 $14M 36k 372.58
Moderna (MRNA) 4.8 $13M 85k 153.58
BioMarin Pharmaceutical (BMRN) 4.3 $12M 119k 97.24
Seagen 3.8 $10M 51k 202.47
Iveric Bio 3.6 $9.8M 405k 24.33
Eli Lilly & Co. (LLY) 3.4 $9.2M 27k 343.42
Sarepta Therapeutics Call Call Option 3.1 $8.3M 60k 137.83
Novo-nordisk A S Call Call Option 2.9 $8.0M 50k 159.14
Astrazeneca Sponsored Adr (AZN) 2.6 $7.1M 102k 69.41
Karuna Therapeutics Put Put Option 2.0 $5.4M 30k 181.64
Biontech Se Sponsored Ads (BNTX) 1.7 $4.6M 37k 124.57
Neurocrine Biosciences (NBIX) 1.7 $4.6M 45k 101.22
Reata Pharmaceuticals Cl A 1.3 $3.6M 40k 90.92
Alnylam Pharmaceuticals (ALNY) 1.2 $3.2M 16k 200.32
Thermo Fisher Scientific (TMO) 1.1 $2.9M 5.1k 576.37
Intra Cellular Therapies (ITCI) 0.8 $2.3M 42k 54.15
Vertex Pharmaceuticals Incorporated (VRTX) 0.8 $2.2M 7.1k 315.07
Verona Pharma Sponsored Ads (VRNA) 0.7 $1.8M 91k 20.08
Cymabay Therapeutics 0.5 $1.5M 169k 8.72
Charles River Laboratories (CRL) 0.5 $1.4M 6.9k 201.82
Roivant Sciences SHS (ROIV) 0.4 $1.2M 158k 7.38
Viking Therapeutics (VKTX) 0.4 $1.1M 68k 16.65
Fibrogen (FGEN) 0.4 $967k 52k 18.66
Waters Corporation (WAT) 0.3 $881k 2.8k 309.63
Vaxcyte (PCVX) 0.3 $853k 23k 37.48
Tyra Biosciences (TYRA) 0.3 $727k 45k 16.07
Altimmune Call Call Option 0.2 $422k 100k 4.22
Amarin Corp Spons Adr New (AMRN) 0.1 $385k 257k 1.50
Amylyx Pharmaceuticals (AMLX) 0.1 $245k 8.3k 29.34
Legend Biotech Corp Sponsored Ads (LEGN) 0.1 $241k 5.0k 48.22
Larimar Therapeutics (LRMR) 0.1 $172k 38k 4.53